NRX Pharmaceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $6.21M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $1.13M, a 19.69% decline year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $1.56M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $6.93M, a 3813.01% increase year-over-year.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2021 was $9.62M, a 273.17% increase from fiscal 2020.
- NRX Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2020 was $2.58M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $6.21M 10-Q · filed 2025-11-14 | |
| 2021-12-31 | $9.62M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.13M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.56M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $6.93M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $2.58M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.41M 10-Q/A · filed 2022-08-12 | |
| 2020-03-31 | $177.03K 10-Q/A · filed 2022-08-12 | |
| 2017-12-31 | $25.00K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |